NVision Quantum Technologies
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $68M
Investors
- 11
About NVision Quantum Technologies
Based in Ulm, Germany, and founded in 2015, NVision Quantum Technologies GmbH operates as a developer of quantum technology designed to enhance medical imaging and detect the effects of cancer therapy at the tissue level. The company was co-founded by Ilai Schwartz (CTO), Martin Plenio, and Alex Retzker. The company offers polarizers utilizing a method called parahydrogen-induced polarization (PHIP), leveraging advancements in quantum physics, chemistry, and engineering to transform metabolic MRIs that allow for early diagnosis and quicker assessment of treatment effectiveness. By employing hyperpolarization technology, the company enables the evaluation of human and animal metabolism through standard MRI, thereby facilitating applications in both preclinical and clinical settings. These include cancer diagnosis methods and the monitoring of therapy response.
Who invested in NVision Quantum Technologies
11 investors across 2 rounds
See all investors in NVision Quantum Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NVision Quantum Technologies
Who invested in NVision Quantum Technologies?
NVision Quantum Technologies has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NVision Quantum Technologies raised?
NVision Quantum Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NVision Quantum Technologies last raise money?
NVision Quantum Technologies's most recent round on record is a Series A, in Jan 2025.
What does NVision Quantum Technologies do?
Based in Ulm, Germany, and founded in 2015, NVision Quantum Technologies GmbH operates as a developer of quantum technology designed to enhance medical imaging and detect the effects of cancer therapy at the tissue level.
Where is NVision Quantum Technologies headquartered?
NVision Quantum Technologies is headquartered in Ulm, Germany.
Which VCs invest in companies like NVision Quantum Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at NVision Quantum Technologies's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like NVision Quantum Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.